Ingredients |
Processing |
Packaging |
Market Trends |
Regulatory |
Interview |
Food Safety |
Instrumentation |
Garuda International signs distribution agreement with Cypress Systems
16 November 2006
Email This | 
Printer Friendly
Garuda International and Cypress Systems have signed a worldwide distribution agreement to serve the functional-food and specialty-nutrition markets with Cypress’ line of yeast-based mineral products.
“We are pleased to include SelenoExcell in our product lineup," says Bassam Faress, director of sales and marketing at Garuda International. "We feel that natural products and ingredients should be backed by science. We are excited to join efforts with Cypress Systems.”
Cypress’ flagship product is SelenoExcell High Selenium Yeast, which holds a Clinical Trial Agreement (CTA) with the Cancer Prevention Division of the National Cancer Institute. SelenoExcell High selenium Yeast is currently the sole intervention agent in a series of cancer-prevention (colon, lung and prostate) and health-related trials.
A GRAS (Generally Regarded As Safe) Assessment has been completed on SelenoExcell.
“We are pleased to include SelenoExcell in our product lineup," says Bassam Faress, director of sales and marketing at Garuda International. "We feel that natural products and ingredients should be backed by science. We are excited to join efforts with Cypress Systems.”
Cypress’ flagship product is SelenoExcell High Selenium Yeast, which holds a Clinical Trial Agreement (CTA) with the Cancer Prevention Division of the National Cancer Institute. SelenoExcell High selenium Yeast is currently the sole intervention agent in a series of cancer-prevention (colon, lung and prostate) and health-related trials.
A GRAS (Generally Regarded As Safe) Assessment has been completed on SelenoExcell.
Del.icio.us | 
Facebook |
